Krishna Institute of Medical Sciences (KIMS) reported a consolidated net profit of ₹79 crore for the quarter ended June 30, 2025 (Q1 FY26), registering a 9.2% year-on-year decline compared to ₹87 crore in the same quarter last year.
The company’s revenue from operations rose sharply by 27% to ₹872 crore, up from ₹688 crore in Q1 FY25. The strong top-line growth was supported by higher patient volumes and expanded service offerings across its hospital network.
Earnings before interest, tax, depreciation, and amortization (EBITDA) stood at ₹193 crore for the quarter, marking an 8% growth from ₹179 crore a year ago. However, the EBITDA margin contracted to 22% from 26% last year, reflecting higher operating costs and employee-related expenses.
Sequentially, the Q1 net profit was down from ₹106 crore reported in Q4 FY25. Revenue was also higher sequentially, rising from ₹797 crore.
KIMS continues to maintain strong operational scale across its network of hospitals in southern India and is exploring both organic and inorganic opportunities to drive growth in the coming quarters.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
